Transdiagnostic Cognitive Behavioral Treatment for Anxiety

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2022

Conditions
Anxiety Disorders
Interventions
BEHAVIORAL

Intensive Cognitive Behavior Therapy (iCBT)

Participants randomized to iCBT will receive 16 hours of cognitive behavioral therapy for anxiety over one weekend. The treatment entails psychoeducation, cognitive restructuring and exposure exercises.

BEHAVIORAL

Standard Cognitive Behavior Therapy (sCBT)

Participants randomized to sCBT will receive 16 hours of cognitive behavioral therapy for anxiety weekly over a period of 12 weeks. The treatment entails psychoeducation, cognitive restructuring and exposure exercises.

Trial Locations (1)

77030

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03810456 - Transdiagnostic Cognitive Behavioral Treatment for Anxiety | Biotech Hunter | Biotech Hunter